Electronic Integration Costs
Career Development: Cold Calling, Networking, and More
Supreme Court to Consider Sales Rep Overtime
New Industry Models: The Blurring Lines Between Drug Safety, Regulation, and Access
No Free Lunches for AIDS Research in Europe
Signal Prioritization
Impact of Affordable Care Act on Pharmaceutical Industry
Keeping a Cool Head Amidst Turmoil
The new Executive Director of the EMA has managed to stay calm under financial and political pressure.
How Much Information for Informed Consent?
European Forum for Good Clinical Practice meeting on informed consent draws a huge crowd.
Looking Beyond the Euro Turmoil
Europe's struggling economies may have unexpected effects on the pharmaceutical sector.
A Race to the Finish for CTs in Europe?
Patricia Brunko addresses the decline in European clinical trials, but still gives the industry hope.
EU Agencies Update
The management board has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director, and the monitoring of the Agency's performance.
An Update to Real Innovation
The Innovative Medicines Initative has launched several projects to improve quality of life.
Staying Vigilant on EU Pharmacovigilance
EU's new rules will be influenced by more than just those primarily responsible for pharmaceuticals.
Many Hands Molding Europe's New CT Rules
Change the CT Rules, but to What Precisely?
A meeting in July to discuss changes to the old rules explored the need for compromise across the industry.
Fighting for Territory and Funding in Europe
A newly released report has the pharma industry facing some new rivals.
Getting Personal Over Personalized Medicine
A potential solution for many, personalized medicine still faces economic, regulatory, and cultural challenges.
Innovation is in for EU's Healthcare System
Europe aism to increase jobs and growth through its "Europe 2020" strategy.
EU Regulation: Help From a Guiding Hand
March marked a busy month for the UE with guidance updates and the launch of new medicine research.
Revisions to the Clinical Trials Directive
The European Union is accepting input regarding changes to the directive until the end of May.
H1N1 Influenza: Not to be Sneezed at
Renewed pandemic fears drawn the sting from criticisms of industry and regulators.
The New Year Brings Same Old Battles
An alliance between two European leaders gives hope for unison but falls short on solutions.
Transparency Rides Again
The European Medicines Agency responds to concerns over conflict of interest and openness.
Conducting Clinical Trials Beyond Europe
Routine inspections and regulations can help maintain GCP standards in global trials.
Crisis Squeezes Clinical Trials Regulation
The NICE will possess greater power, scope, and status under the new system.
Deconstructing Relative Effectiveness Efforts
European network could bring confusion to health technology assessment and clinical research.
Good, Bad or Indifferent?
The verdict is awaited on the much criticized and long anticipated European clinical trials directive.
Changing Medicines, Changing Rules
New guidelines are being developed in Europe to address questions regarding stem-cell medicines.
